{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "I",
                    "alt": "T",
                    "position": "1915"
                },
                "variant_string_id": "LRRK2 I1915T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Gain - of - function mutations in leucine - rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age - dependent dopaminergic neuron (DN) degeneration. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. E2F1/DP overproduction, previously implicated in cell cycle and survival control, is critical for LRRK2 pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that LRRK2 gain - of - function mutations cause PD with DN degeneration, and the mechanism involves interaction with the miRNA pathway to regulate protein synthesis and E2F1/DP overproduction.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays used include in vivo EGFP reporter with let - 7 - binding sites in the 3′UTR to monitor miRNA activity, luciferase reporter assays in HEK293T cells, co - immunoprecipitation (co - IP) assays to study protein - protein interactions, Western blot analysis to measure protein levels, and various genetic manipulation assays in Drosophila.",
                    "judgment": "Yes",
                    "reasoning": "The assays such as reporter assays and co - IP assays are relevant to studying the interaction of LRRK2 with the miRNA pathway, which is part of the defined disease mechanism. The genetic manipulation assays in Drosophila help in understanding the in vivo effects related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Each measurement in assays like climbing activity assay was repeated using three independent fly cohorts per genotype. Unpaired Student's t - tests were used for statistical analysis between two groups and one - way ANOVA analysis for statistical analysis involving more than two experimental groups. For co - immunoprecipitation in HEK293 cells, cells were co - transfected with hLRRK2 constructs and Flag - tagged human Ago2. For Western blotting, multiple primary antibodies were used. Data in qPCR was generated from three independent qPCR reactions and normalized with rp49 mRNA level as control. In reporter assays, luciferase activity was normalized with renilla mRNA level. However, it is not clear if both normal/negative/wild - type and abnormal/positive/null controls were used for all assays.",
                    "judgment": "No",
                    "reasoning": "Although there is evidence of replicates in some assays, the information about the use of both normal/negative/wild - type and abnormal/positive/null controls for all assays is not clear. So, we proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Many of the techniques like co - immunoprecipitation, Western blotting, reporter assays are standard techniques in the field. The RNAhybrid algorithm, a well - known method, was used to predict potential miRNA - binding sites.",
                    "judgment": "Yes",
                    "reasoning": "The use of standard techniques like co - immunoprecipitation, Western blotting, and reporter assays, along with the use of a well - known algorithm for miRNA - binding site prediction, indicates that the specific instances of the assays are either broadly accepted historically or previously validated in the field.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "Based on the ACMG functional evidence evaluation flowchart, the disease mechanism was clearly defined. The assays used were applicable to the disease mechanism. Since basic controls and replicates were not clearly established for all assays, but the assays are standard in the field, the functional evidence strength for the LRRK2 I1915T variant is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "S",
                    "position": "2019"
                },
                "variant_string_id": "LRRK2 G2019S"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Gain - of - function mutations in leucine - rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age - dependent dopaminergic neuron (DN) degeneration. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. E2F1/DP overproduction, previously implicated in cell cycle and survival control, is critical for LRRK2 pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that LRRK2 gain - of - function mutations cause PD with DN degeneration, and the mechanism involves interaction with the miRNA pathway to regulate protein synthesis and E2F1/DP overproduction.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays used include in vivo EGFP reporter with let - 7 - binding sites in the 3′UTR to monitor miRNA activity, luciferase reporter assays in HEK293T cells, co - immunoprecipitation (co - IP) assays to study protein - protein interactions, Western blot analysis to measure protein levels, and various genetic manipulation assays in Drosophila.",
                    "judgment": "Yes",
                    "reasoning": "The assays such as reporter assays and co - IP assays are relevant to studying the interaction of LRRK2 with the miRNA pathway, which is part of the defined disease mechanism. The genetic manipulation assays in Drosophila help in understanding the in vivo effects related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Each measurement in assays like climbing activity assay was repeated using three independent fly cohorts per genotype. Unpaired Student's t - tests were used for statistical analysis between two groups and one - way ANOVA analysis for statistical analysis involving more than two experimental groups. For co - immunoprecipitation in HEK293 cells, cells were co - transfected with hLRRK2 constructs and Flag - tagged human Ago2. For Western blotting, multiple primary antibodies were used. Data in qPCR was generated from three independent qPCR reactions and normalized with rp49 mRNA level as control. In reporter assays, luciferase activity was normalized with renilla mRNA level. However, it is not clear if both normal/negative/wild - type and abnormal/positive/null controls were used for all assays.",
                    "judgment": "No",
                    "reasoning": "Although there is evidence of replicates in some assays, the information about the use of both normal/negative/wild - type and abnormal/positive/null controls for all assays is not clear. So, we proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Many of the techniques like co - immunoprecipitation, Western blotting, reporter assays are standard techniques in the field. The RNAhybrid algorithm, a well - known method, was used to predict potential miRNA - binding sites.",
                    "judgment": "Yes",
                    "reasoning": "The use of standard techniques like co - immunoprecipitation, Western blotting, and reporter assays, along with the use of a well - known algorithm for miRNA - binding site prediction, indicates that the specific instances of the assays are either broadly accepted historically or previously validated in the field.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "Based on the ACMG functional evidence evaluation flowchart, the disease mechanism was clearly defined. The assays used were applicable to the disease mechanism. Since basic controls and replicates were not clearly established for all assays, but the assays are standard in the field, the functional evidence strength for the LRRK2 G2019S variant is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "I",
                    "alt": "T",
                    "position": "2020"
                },
                "variant_string_id": "LRRK2 I2020T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Gain - of - function mutations in leucine - rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age - dependent dopaminergic neuron (DN) degeneration. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. E2F1/DP overproduction, previously implicated in cell cycle and survival control, is critical for LRRK2 pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that LRRK2 gain - of - function mutations cause PD with DN degeneration, and the mechanism involves interaction with the miRNA pathway to regulate protein synthesis and E2F1/DP overproduction.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays used include luciferase reporter assays in HEK293T cells to study the effect on miRNA - regulated translation, which is relevant to the LRRK2 - miRNA pathway interaction in the disease mechanism.",
                    "judgment": "Yes",
                    "reasoning": "The luciferase reporter assay in HEK293T cells is relevant to studying the impact of LRRK2 on miRNA - regulated translation, which is part of the defined disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "It is not clear if both normal/negative/wild - type and abnormal/positive/null controls were used, and there is no clear indication of multiple replicates for this specific variant's assays.",
                    "judgment": "No",
                    "reasoning": "Lack of clear information on both types of controls and replicates for this variant's assays. Proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Luciferase reporter assays are a standard technique in the field for studying gene regulation and miRNA - mRNA interactions.",
                    "judgment": "Yes",
                    "reasoning": "The luciferase reporter assay is a standard technique, so the specific instance of the assay is broadly accepted historically in the field.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "Based on the ACMG functional evidence evaluation flowchart, the disease mechanism was defined. The assay used was applicable. Due to lack of clear basic controls and replicates, but with the assay being a standard one, the functional evidence strength for the LRRK2 I2020T variant is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "G",
                    "position": "1441"
                },
                "variant_string_id": "LRRK2 R1441G"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Gain - of - function mutations in leucine - rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age - dependent dopaminergic neuron (DN) degeneration. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. E2F1/DP overproduction, previously implicated in cell cycle and survival control, is critical for LRRK2 pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that LRRK2 gain - of - function mutations cause PD with DN degeneration, and the mechanism involves interaction with the miRNA pathway to regulate protein synthesis and E2F1/DP overproduction.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The paper shows that mutant hLRRK2 carrying R1441G mutation had no effect on let - 7 miRNA function, and transgenic flies expressing dLRRK carrying the equivalent R1069G mutation showed no DN loss. But no specific assays for this variant's functional mechanism are detailed.",
                    "judgment": "No",
                    "reasoning": "Insufficient information about the general class of assay used for this variant to determine its applicability to the disease mechanism. Do not use PS3/BS3.",
                    "next_step_or_outcome": "Do not use PS3/BS3"
                }
            ],
            "final_evidence_strength": {
                "type": "N/A",
                "strength": "N/A"
            },
            "overall_conclusion": "Based on the ACMG functional evidence evaluation flowchart, although the disease mechanism was defined, due to lack of information on the assay applicable to this variant's functional study, no functional evidence strength can be assigned."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "G",
                    "position": "1069"
                },
                "variant_string_id": "LRRK2 R1069G"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Gain - of - function mutations in leucine - rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age - dependent dopaminergic neuron (DN) degeneration. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. E2F1/DP overproduction, previously implicated in cell cycle and survival control, is critical for LRRK2 pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that LRRK2 gain - of - function mutations cause PD with DN degeneration, and the mechanism involves interaction with the miRNA pathway to regulate protein synthesis and E2F1/DP overproduction.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The paper shows that transgenic flies expressing dLRRK carrying the R1069G